Details for 2014786429

Up to date per 02.04.2026

Actions

Title / Product Name

FORMULIERUNGEN VON (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYLOXY)-1-OXOISOINDOLIN-2-YL)PIPERIDIN-2,6-DION

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2014786429

EP Publication Number

3054927

E-Number

1097268

Language

PCT Number

US14059424

Publication Date

17.08.2016 A

20.02.2019 B1

Registration Date

20.02.2019

AT Publication Date

15.03.2019

Application Date

07.10.2014

Registration Number

Priorities

08.10.2013

201361888419 P

IPC

A61K 9/48 20060101AFI20160711BHEP

Maximum Duration of Protection

07.10.2034

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

PARIKH, Darshan1605 Vroom Drive Bridgewater, NJ 08807US

MENON, Anil1717 Merriam Drive Martinsville, NJ 08836US

Information about Fees